NeuroAI will participate in MaRS Impact Health, one of Canada’s premier health innovation events, taking place on April 23, 2026, at the MaRS Centre.
Hosted by MaRS Discovery District, the annual summit convenes more than 1,000 attendees, 100+ speakers and 75+ startups from across digital health, medical devices and biotech. The event focuses on accelerating the commercialization of breakthrough technologies, supporting healthcare professionals and improving patient outcomes.
As part of this year’s program, NeuroAI’s CEO and Co-Founder, Asif Hasan, will be a featured speaker. Hasan is an entrepreneur and technology leader known for building ventures at the intersection of innovation and human impact. Through NeuroAI, he is advancing AI-driven tools designed to support caregivers and clinicians and improve access to neurodevelopmental care.
MaRS Impact Health features two stages of programming, including the Catalyst stage, focused on system- and market-level transformation, and a Founder-focused stage dedicated to building and scaling health ventures. Sessions span three key tracks: Digital Health, Medical Devices, and Biotech & Life Sciences.
NeuroAI’s participation reinforces its commitment to developing clinically grounded, human-centered technologies that address critical gaps in healthcare systems.
April 23, 2026
MaRS Centre: 101 College Street, Toronto, Ontario
For more information, visit: impacthealth.marsdd.com.
Media Contact (NeuroAI)
Samara Kalil | Marketing & Community Manager
samara.kalil@neuroai.ca